CLINICAL TRIALS PROFILE FOR AMLODIPINE AND OLMESARTAN MEDOXOMIL

« Back to Dashboard

All Clinical Trials for AMLODIPINE AND OLMESARTAN MEDOXOMIL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00185133 ↗	Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension	Completed	Daiichi Sankyo Inc.	Phase 3	2005-05-01	This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
NCT00185133 ↗	Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension	Completed	Daiichi Sankyo, Inc.	Phase 3	2005-05-01	This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
NCT00220220 ↗	Amlodipine as add-on to Olmesartan in Hypertension	Completed	Sankyo Pharma Gmbh	Phase 3	2005-04-01	Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.
NCT00220233 ↗	Olmesartan as an add-on to Amlodipine in Hypertension	Completed	Sankyo Pharma Gmbh	Phase 3	2005-04-01	This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone
NCT00311155 ↗	Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension	Completed	Sankyo Pharma Gmbh	Phase 4	2006-03-01	This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.

Clinical Trial Conditions for AMLODIPINE AND OLMESARTAN MEDOXOMIL

Condition Name

Condition Name for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Intervention	Trials
Essential Hypertension	6
Hypertension	6
Healthy Subjects	2
Type 2 Diabetes	1

Condition MeSH

Condition MeSH for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Intervention	Trials
Hypertension	12
Essential Hypertension	6
Metabolic Syndrome X	1
Metabolic Syndrome	1

Clinical Trial Locations for AMLODIPINE AND OLMESARTAN MEDOXOMIL

Trials by Country

Trials by Country for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Location	Trials
United States	122
Germany	5
Philippines	3
Italy	2
Belgium	2

Trials by US State

Trials by US State for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Location	Trials
Florida	4
Virginia	4
California	4
Texas	4
Tennessee	4

Clinical Trial Progress for AMLODIPINE AND OLMESARTAN MEDOXOMIL

Clinical Trial Phase

Clinical Trial Phase for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	7
Phase 1	2

Clinical Trial Status

Clinical Trial Status for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Clinical Trial Phase	Trials
Completed	13
Terminated	1

Clinical Trial Sponsors for AMLODIPINE AND OLMESARTAN MEDOXOMIL

Sponsor Name

Sponsor Name for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Sponsor	Trials
Daiichi Sankyo Inc.	6
Daiichi Sankyo, Inc.	6
Sankyo Pharma Gmbh	3

Sponsor Type

Sponsor Type for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Sponsor	Trials
Industry	23